Popular Articles

$940,000 In Stimulus Funds Won By UTSA Biologists To Advance Research: 2 Studies Will Focus On Food Safety And Disease Prevention
San Antonio ò€¦ Robert Renthal, professor of biochemistry in the College of Sciences" Department of Biology at The University of Texas at San Antonio and JosÓ© Lopez-Ribot, professor of microbiology in UTSA"s Department of Biology and a member of the university"s South Texas Center for Emerging Infectious Diseases, have received a combined $940,000 in stimulus funding from the National Institutes of Health to further their research over the next two years.

Delaware State Senate Passes Bill Aimed At Reducing Mother-To-Child HIV Transmission
The Delaware State Senate recently passed a bill (SB 86) that would add HIV testing to the standard battery of tests given to all pregnant women, WMTD.com reports. Lawmakers hope that the bill will help reduce the rate of mother-to-child HIV transmission. Women would be able to choose to "opt out" of taking the test, according to WMTD.com (Saki, WMTD.com, 6/14).
News of the day
Enzyme Necessary For DNA Synthesis Can Also Erase DNA
In this week"s edition of Proceedings of the National Academy of Sciences, PNAS, Uppsala University scientists describe a new mechanism behind an important process that causes a rapid reduction of DNA in the chromosomes of bacteria. The findings advance our knowledge of how DNA content has been reduced, which is something that has occurred in bacteria that live as parasites inside the cells of other organisms.
Mental Health

Osmetech Submits Swine Flu Test To The FDA

Osmetech (LSE:OMH) announced that it has submitted a request to the US FDA for Emergency Use Authorization (EUA) for its Respiratory Pathogen Test Panel test to be used to screen for the swine flu virus. Osmetech"s Respiratory Pathogen Test Panel test, which is expected to be launched as a research use only (RUO) product next quarter, detects and differentiates between 18 common bacterial and viral infections, including the Influenza A virus and its H1N1 subtype. Osmetech is currently developing an extension to the Respiratory Pathogen Test that will differentiate this H1N1 subtype between the human and swine forms of the virus. Osmetech Respiratory Pathogen Test Panel test has been adapted from QIAGEN"s QIAplex-based respiratory viral test for use on Osmetech"s eSensor XT-8 molecular diagnostics system, under the terms of an agreement signed in September 2008. James White, Chief Executive, Osmetech plc, said: "We believe that our test is ideally suited for fast and reliable screening of Influenza A virus types, including the swine flu strain which is currently a major pandemic concern. The test will be run on our eSensor XT-8 platform, which is a small, portable and easy to use platform that has the potential to enable testing to occur in numerous locations." About Swine Flu Swine flu (swine influenza) is a highly contagious respiratory disease of pigs, caused by one of several swine influenza A viruses. Since pigs can be infected with more than one virus type at a time, genes of several viruses from various s (including humans) can mix, allowing the swine influenza viruses to cross species barrier and eventually cause disease in humans. The clinical symptoms then are similar to seasonal influenza and other acute upper respiratory tract infections, in some cases leading to severe pneumonia and resulting in death. However, since mild or asymptomatic cases may have escaped from recognition, the true extent of this disease among humans is still unknown. Currently, there is no human vaccine on the market which protects against swine influenza. Antiviral drugs are available in many countries. More information on the swine flu is available on http://www.who.int/. Osmetech plc *See our Map Of H1N1 Outbreaks *See our Mexico Swine Flu Blog


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):